Day One at CPHI Frankfurt Sees Announcements from ACG and Bora Pharmaceuticals

Published on: October 28, 2025

ACG showcased the expansion of its European presence, and Bora Pharmaceuticals participates in a discussion about CDMO innovation.

CPHI Frankfurt opened today, October 28, with conference sessions on a variety of topics and a wide range of companies exhibiting their products and services. Contract development and manufacturing organization (CDMO), ACG, chose CPHI Frankfurt to showcase the expansion of its services in Europe with the anticipation of shorter lead times, more robust supply chains, and local support from pharma manufacturers. In particular, the company’s Croatian operations, is one of Europe’s largest capsule production sites, according to the company (1).

Which products is ACG exhibiting?

At stand 8.0T60 Zone Excipients, ACG is also exhibiting its gelatin capsule portfolio, which is now manufactured in Europe, and includes inhalation capsules, TiO2 -free options, liquid-fill formats, and a cellulose-based capsule with a pH-independent profile for moisture-sensitive formulations. The company’s range of high- and ultra-high barrier blister packaging is also on display.

“ACG is driving sustainability through PVC free and design for recyclability thermoforming options, PVC and halogen free cold forming material and lighter weight materials. ACG’s CelluPod, a paper-based blister and Bio D, a biodegradable PVC film. ACG’s packaging materials are produced from premium and traceable raw materials and are fully compliant with global regulations, provides reliability and consistence in product quality,” Jochen Scheil, ACG’s Vice President Global Sales & Business Development said in a press release (1).

“Our focus is on being in Europe, for Europe, combining global expertise with local presence to deliver real value for our customers,” said Selwyn Noronha, CEO of ACG Capsules, in the release (1). “By strengthening our operations in Croatia, we’re increasing capacity, shortening lead times and enhancing supply chain resilience. Together with our integrated solutions and deep understanding of European standards, this investment ensures we remain a trusted partner, always at our customers’ side.”

How will innovation in outsourcing be discussed this year?

The CEO of Bora Pharmaceuticals, a CDMO that specializes in formulation development, clinical and commercial manufacturing, and packaging, will be exhibiting and presenting this year. Bora CDMO president, J.D. Mowery, is participating in a panel discussion on the future of CDMO innovation. Beyond Traditional Markets: The Strategic Importance of Emerging Pharma Trends and CDMO Innovation explores the emerging trends shaping CDMOs and is scheduled for October 30 from 11:35 a.m. to 12:15 p.m.

Look for our 2-part interview with Mowery to post on Thursday.

The company will also be announcing the expansion of its fill/finish capabilities in the CDMO Zone at Booth 6.0C90. In addition, the company’s Chairman and CEO, Bobby Sheng is a finalist for “CEO of the Year” in the CPHI Awards. Sheng won “CEO of the Year” in 2020.

“Bringing leaders and ideas together under one roof to collaborate is critical to the future growth of our industry,” said Mowery in a press release (2). “This has been an exciting year at Bora, marked by global growth and strategic investments across our business. We’re eager to make the most of the connections and collaboration at CPHI and carry those insights back to our customers to further strengthen the value we deliver.”

“Our collaboration with Bora Pharmaceuticals for sterile fill and finish services truly distinguishes us from other biologic CDMOs,” Marc Goemans, chief commercial officer of Bora Biologics, emphasized. “It streamlines the client experience by allowing them to sign a single agreement to work with one team on one timeline, ensuring expedited project success from start to finish—consolidating expertise and rewarding collaboration to de-risk every project."

The CPHI Frankfurt Pharma Awards will be announced at the event’s opening ceremony on October 28 (3).

References

ACG. ACG Showcases Strengthened European Capabilities and Croatia Expansion at CPHI 2025. Press Release. Oct. 28, 2025
Bora Pharmaceuticals. Bora Pharmaceuticals Joins Global Pharma Leaders at CPHI 2025. Press Release. Oct. 27, 2025.
Mirasol, F. CPHI Frankfurt Reveals 2025 Pharma Awards Finalists for Bio/Pharma Development. PharmTech.com. Sept. 18, 2025. https://www.pharmtech.com/view/cphi-frankfurt-reveals-2025-pharma-awards-finalists-for-bio-pharma-development